Skip to main content

Advertisement

Log in

Pathological properties of the Parkinson’s disease-associated protein DJ-1 in α-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick’s disease

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Mutations in the PARK7 gene DJ-1 are associated with recessive hereditary Parkinson’s disease (PD). Fibrillar inclusions of α-synuclein comprise the neuropathological hallmarks of PD and related Lewy body diseases as well as multiple system atrophy (MSA). Moreover, neuronal and glial inclusions containing tau have been observed in α-synucleinopathy patients. Using a collection of antibodies against DJ-1, we have performed a comprehensive investigation of DJ-1 in α-synucleinopathies and tauopathies. DJ-1 was abundantly expressed in reactive astrocytes of patients with neurodegenerative diseases. Likewise, DJ-1 antiserum immunostained reactive astrocytes that became abundant with disease progression in the brain stem of transgenic mice expressing mutant [A30P]α-synuclein. Human Lewy bodies as well as Lewy body-like inclusions in the α-synuclein transgenic mice were DJ-1 negative. Neuronal tau inclusions were DJ-1 immunopositive in Pick’s disease (PiD), corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), and Alzheimer’s disease. In addition, we found DJ-1-immunopositive glial inclusions in CBD, PSP and MSA. Biochemical extraction experiments revealed the specific presence of insoluble, modified DJ-1 in PiD and MSA. Our results suggest that DJ-1 is up-regulated in reactive astrocytes as well as in neuronal and glial cells with specific α-synucleinopathy and tauopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Abou-Sleiman PM, Healy DG, Quinn N, Lees AJ, Wood NW (2003) The role of pathogenic DJ-1 mutations in Parkinson’s disease. Ann Neurol 54:283–286

    Article  CAS  PubMed  Google Scholar 

  2. Bonifati V, Rizzu P, Baren MJ van, Schaap O, Breedveld GJ, Krieger E, Dekker MCJ, Squitieri F, Ibanez P, Joosse M, Dongen JW van, Vanacore N, Swieten JC van, Brice A, Meco G, Duijn CM van, Oostra BA, Heutink P (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256–259

    Article  CAS  PubMed  Google Scholar 

  3. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259

    CAS  PubMed  Google Scholar 

  4. Braak H, Del Tredici K, Sandmann-Kiel D, Rüb U, Schultz C (2001) Nerve cells expressing heat-shock proteins in Parkinson’s disease. Acta Neuropathol 102:449–454

    CAS  PubMed  Google Scholar 

  5. Buée L, Delacourte A (1999) Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick’s disease. Brain Pathol 9:681–693

    PubMed  Google Scholar 

  6. Cairns NJ, Atkinson PF, Hanger DP, Anderton BH, Daniel SE, Lantos PL (1997) Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer’s disease. Neurosci Lett 230:49–52

    Article  CAS  PubMed  Google Scholar 

  7. Cookson MR (2003) Crystallizing ideas about Parkinson’s disease. Proc Natl Acad Sci USA 100:9111–9113

    Article  CAS  PubMed  Google Scholar 

  8. Dekker M, Bonifati V, Van Swieten J, Leenders N, Galjaard RJ, Snijders P, Horstink M, Heutink P, Oostra B, Van Duijn C (2003) Clinical features and neuroimaging of PARK7-linked parkinsonism. Mov Disord 18:751–757

    Article  PubMed  Google Scholar 

  9. Dickson DW (2001) α-Synuclein and the Lewy body disorders. Curr Opin Neurol 14:423–432

    Article  CAS  PubMed  Google Scholar 

  10. Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, Biaggioni I, Hurtig HI, Stern MB, Gollomp SM, Grossman M, Lee VM-Y, Trojanowski JQ (2000) Immunohistochemical and biochemical studies demonstrate a distinct profile of α-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol 59:830–841

    CAS  PubMed  Google Scholar 

  11. Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VM-Y (2003) Initiation and synergistic fibrillization of tau and α-synuclein. Science 300:636–640

    Article  CAS  PubMed  Google Scholar 

  12. Giasson BI, Lee VM-Y, Trojanowski JQ (2003) Interactions of amyloidogenic proteins. NeuroMolecular Med 4:49–58

    Article  CAS  PubMed  Google Scholar 

  13. Giasson BI, Mabon ME, Duda JE, Montine TJ, Robertson D, Hurtig HI, Lee VM-Y, Trojanowski JQ (2003) Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy. Acta Neuropathol 106:243–250

    Article  CAS  PubMed  Google Scholar 

  14. Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2:492–501

    CAS  PubMed  Google Scholar 

  15. Goedert M, Jakes R, Crowther RA, Cohen P, Vanmechelen E, Vandermeeren M, Cras P (1994) Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer’s disease: identification of phosphorylation sites in tau protein. Biochem J 301:871–877

    CAS  PubMed  Google Scholar 

  16. Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189:167–169

    CAS  PubMed  Google Scholar 

  17. Görner K, Holtorf E, Odoy S, Nuscher B, Yamamoto A, Regula JT, Beyer K, Haass C, Kahle PJ (2004) Differential effects of Parkinson’s disease-associated mutations on stability and folding of DJ-1. J Biol Chem 279:6943–6951

    Article  PubMed  Google Scholar 

  18. Hague S, Rogaeva E, Hernandez D, Gulick C, Singleton A, Hanson M, Johnson J, Weiser R, Gallardo M, Ravina B, Gwinn-Hardy K, Crawley A, St. George-Hyslop PH, Lang AE, Heutink P, Bonifati V, Hardy J, Singleton A (2003) Early-onset Parkinson’s disease caused by a compound heterozygous DJ-1 mutation. Ann Neurol 54:271–274

    Article  CAS  PubMed  Google Scholar 

  19. Hod Y, Pentyala SN, Whyard TC, El-Maghrabi MR (1999) Identification and characterization of a novel protein that regulates RNA-protein interaction. J Cell Biochem 72:435–444

    Article  CAS  PubMed  Google Scholar 

  20. Jellinger KA (2003) Neuropathological spectrum of synucleinopathies. Mov Disord 18 (Suppl 6):S2–12

    Article  PubMed  Google Scholar 

  21. Kahle PJ, Neumann M, Ozmen L, Müller V, Jacobsen H, Schindzielorz A, Okochi M, Leimer U, Putten H van der, Probst A, Kremmer E, Kretzschmar HA, Haass C (2000) Subcellular localization of wild-type and Parkinson’s disease-associated mutant α-synuclein in human and transgenic mouse brain. J Neurosci 20:6365–6373

    CAS  PubMed  Google Scholar 

  22. Kato S, Nakamura H (1990) Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies. Acta Neuropathol 79:584–594

    CAS  PubMed  Google Scholar 

  23. Lee S-J, Kim SJ, Kim I-K, Ko J, Jeong C-S, Kim G-H, Park C, Kang S-O, Suh P-G, Lee H-S, Cha S-S (2003) Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain. J Biol Chem 278:44552–44559

    Article  CAS  PubMed  Google Scholar 

  24. Macedo MG, Anar B, Bronner IF, Cannella M, Squitieri F, Bonifati V, Hoogeveen A, Heutink P, Rizzu P (2003) The DJ-1L166P mutant protein associated with early onset Parkinson’s disease is unstable and forms higher-order protein complexes. Hum Mol Genet 12:2807–2816

    Article  CAS  PubMed  Google Scholar 

  25. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, Vos RA de, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124

    CAS  PubMed  Google Scholar 

  26. Miller DW, Ahmad R, Hague S, Baptista MJ, Canet-Aviles R, McLendon C, Carter DM, Zhu P-P, Stadler J, Chandran J, Klinefelter GR, Blackstone C, Cookson MR (2003) L166P mutant DJ-1, causative for recessive Parkinson’s disease, is degraded through the ubiquitin-proteasome system. J Biol Chem 278:36588–36595

    Article  CAS  PubMed  Google Scholar 

  27. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486

    CAS  PubMed  Google Scholar 

  28. Mitsumoto A, Nakagawa Y (2001) DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic Res 35:885–893

    CAS  PubMed  Google Scholar 

  29. Mitsumoto A, Nakagawa Y, Takeuchi A, Okawa K, Iwamatsu A, Takanezawa Y (2001) Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radic Res 35:301–310

    CAS  PubMed  Google Scholar 

  30. Moore DJ, Zhang L, Dawson TM, Dawson VL (2003) A missense mutation (L166P) in DJ-1, linked to familial Parkinson’s disease, confers reduced protein stability and impairs homo-oligomerization. J Neurochem 87:1558–1567

    CAS  PubMed  Google Scholar 

  31. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SMM, Ariga H (1997) DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 231:509–513

    Article  CAS  PubMed  Google Scholar 

  32. Nakazato Y, Yamazaki H, Hirato J, Ishida Y, Yamaguchi H (1990) Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 49:521–530

    CAS  PubMed  Google Scholar 

  33. Neumann M, Adler S, Schlüter O, Kremmer E, Benecke R, Kretzschmar HA (2000) α-Synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies. Acta Neuropathol 100:568–574

    PubMed  Google Scholar 

  34. Neumann M, Kahle PJ, Giasson BI, Ozmen L, Borroni E, Spooren W, Müller V, Odoy S, Fujiwara H, Hasegawa M, Iwatsubo T, Trojanowski JQ, Kretzschmar HA, Haass C (2002) Misfolded proteinase K-resistant hyperphosphorylated α-synuclein in aged transgenic mice with locomotor deterioration and in human α-synucleinopathies. J Clin Invest 110:1429–1439

    Article  CAS  PubMed  Google Scholar 

  35. Niki T, Takahashi-Niki K, Taira T, Iguchi-Ariga SMM, Ariga H (2003) DJBP: A novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. Mol Cancer Res 1:247–261

    CAS  PubMed  Google Scholar 

  36. Olzmann JA, Brown K, Wilkinson KD, Rees HD, Huai Q, Ke H, Levey AI, Li L, Chin L-S (2003) Familial Parkinson’s disease-associated L166P mutation disrupts DJ-1 protein folding and function. J Biol Chem (in press)

  37. Piao Y-S, Hayashi S, Hasegawa M, Wakabayashi K, Yamada M, Yoshimoto M, Ishikawa A, Iwatsubo T, Takahashi H (2001) Co-localization of α-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration. Acta Neuropathol 101:285–293

    CAS  PubMed  Google Scholar 

  38. Rizzu P, Hinkle DA, Zhukareva V, Bonifati V, Severijnen L-A, Martinez D, Ravid R, Kamphorst W, Eberwine JH, Lee VM-Y, Trojanowski JQ, Heutink P (2004) DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia. Ann Neurol 55:113–118

    Article  CAS  PubMed  Google Scholar 

  39. Takahashi K, Taira T, Niki T, Seino C, Iguchi-Ariga SMM, Ariga H (2001) DJ-1 positively regulates the androgen receptor by impairing the binding of PIASxα to the receptor. J Biol Chem 276:37556–37563

    Article  CAS  PubMed  Google Scholar 

  40. Takeda A, Arai N, Komori T, Iseki E, Kato S, Oda M (1997) Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 234:63–66

    Article  CAS  PubMed  Google Scholar 

  41. Tao X, Tong L (2003) Crystal structure of human DJ-1, a protein associated with early onset Parkinson’s disease. J Biol Chem 278:31372–31379

    Article  CAS  PubMed  Google Scholar 

  42. Tolnay M, Probst A (1999) Tau protein pathology in Alzheimer’s disease and related disorders. Neuropathol Appl Neurobiol 25:171–187

    Article  CAS  PubMed  Google Scholar 

  43. Wagenfeld A, Gromoll J, Cooper TG (1998) Molecular cloning and expression of rat contraception associated protein 1 (CAP1), a protein putatively involved in fertilization. Biochem Biophys Res Commun 251:545–549

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank P. Rizzu and P. Heutink for the donation of antisera against DJ-1, I. Pigur and S. Odoy for technical assistance, and M. Farrer for helpful discussions. This work was supported by the German National Genome Research Network (NGFN), the (N)EUROPARK consortium funded by the European Community, and the Deutsche Forschungsgemeinschaft (Collaborative Research Center SFB596 and KFO 113/1). The German Brain Bank “Brain-Net” (http://www.brain-net.net) is supported by the German Federal Ministry of Education and Research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philipp J. Kahle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neumann, M., Müller, V., Görner, K. et al. Pathological properties of the Parkinson’s disease-associated protein DJ-1 in α-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick’s disease. Acta Neuropathol 107, 489–496 (2004). https://doi.org/10.1007/s00401-004-0834-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-004-0834-2

Keywords

Navigation